Cargando…
Letrozole-induced necrotising leukocytoclastic small vessel vasculitis: First report of a case in the UK
INTRODUCTION: Letrozole, an aromatase inhibitor, is a commonly used neo-adjuvant drug to treat hormone-sensitive breast cancer. There have been a few cases of aromatase inhibitor induced vasculitis but the first case of letrozole-induced vasculitis was reported from Switzerland in 2014 (Digklia et a...
Autores principales: | Pathmarajah, Pirunthan, Shah, Karishma, Taghipour, Kathy, Ramachandra, Su, Thorat, Mangesh A, Chaudhry, Ziaullah, Patkar, Vivek, Peters, Francesca, Connor, Thomas, Spurrell, Emma, Tobias, Jeffrey S, Vaidya, Jayant S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643446/ https://www.ncbi.nlm.nih.gov/pubmed/26432999 http://dx.doi.org/10.1016/j.ijscr.2015.09.024 |
Ejemplares similares
-
Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination
por: Fiorillo, G., et al.
Publicado: (2022) -
Vancomycin-Associated Leukocytoclastic Vasculitis
por: Pongruangporn, Makhawadee, et al.
Publicado: (2011) -
Dabigatran Associated Leukocytoclastic Vasculitis
por: Potolidis, Evangelos, et al.
Publicado: (2015) -
Leukocytoclastic vasculitis secondary to clozapine
por: Mukherjee, Shatavisa, et al.
Publicado: (2019) -
Oxacillin-induced leukocytoclastic vasculitis
por: Mericliler, Meric, et al.
Publicado: (2019)